Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
LifeMD
LFMD
$172M
| $409K | ﹤0.01% |
49,373
+26,604
| +117% | +$191K |
|
|
PSTX
3902
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $408K | ﹤0.01% |
121,337
+75,795
| +166% | +$195K |
|
3903
SIGA Technologies
SIGA
$219M
| $407K | ﹤0.01% |
72,733
+56,686
| +353% | +$304K |
|
3904
Greenlight Captial
GLRE
$506M
| $405K | ﹤0.01% |
35,507
+30,829
| +659% | +$343K |
|
3905
Holley
HLLY
$384M
| $405K | ﹤0.01% |
83,064
+65,194
| +365% | +$288K |
|
3906
LCNB Corp
LCNB
$283M
| $404K | ﹤0.01% |
25,639
+12,497
| +95% | +$184K |
|
3907
First Majestic Silver
AG
$9.07B
| $404K | ﹤0.01% |
65,705
+14,752
| +29% | +$81.3K |
|
3908
Legacy Housing
LEGH
$694M
| $403K | ﹤0.01% |
15,969
+12,311
| +337% | +$261K |
|
3909
Enlight Renewable Energy
ENLT
$11.9B
| $401K | ﹤0.01% |
20,951
-270
| -1% | -$4.23K |
|
3910
Utah Medical Products
UTMD
$225M
| $401K | ﹤0.01% |
4,757
+4,102
| +626% | +$340K |
|
3911
Fidelity D&D Bancorp
FDBC
$317M
| $399K | ﹤0.01% |
6,882
+5,525
| +407% | +$280K |
|
3912
Scilex Holding
SCLX
$48.9M
| $399K | ﹤0.01% |
+5,585
| New | +$290K |
|
|
CVLY
3913
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $398K | ﹤0.01% |
15,480
+10,905
| +238% | +$228K |
|
3914
Ranpak Holdings
PACK
$473M
| $396K | ﹤0.01% |
68,001
+52,500
| +339% | +$222K |
|
3915
IBEX
IBEX
$499M
| $396K | ﹤0.01% |
20,815
+10,883
| +110% | +$189K |
|
|
PBPB
3916
DELISTED
Potbelly
PBPB
| $396K | ﹤0.01% |
37,956
+32,444
| +589% | +$295K |
|
3917
MarketWise
MKTW
$56.6M
| $394K | ﹤0.01% |
7,222
+6,925
| +2,332% | +$339K |
|
3918
Direxion Daily Technology Bull 3x ETF
TECL
$6.21B
| $394K | ﹤0.01% |
5,900
-910
| -13% | -$49.4K |
|
3919
Organogenesis Holdings
ORGO
$239M
| $393K | ﹤0.01% |
96,202
+70,926
| +281% | +$199K |
|
3920
Information Services Group
III
$251M
| $393K | ﹤0.01% |
83,370
+48,361
| +138% | +$211K |
|
|
CVAC
3921
DELISTED
CureVac
CVAC
| $392K | ﹤0.01% |
93,217
-4,429
| -5% | -$24K |
|
3922
abrdn Physical Gold Shares ETF
SGOL
$7.41B
| $391K | ﹤0.01% |
19,830
| – | – |
|
3923
Graham Corp
GHM
$1.31B
| $389K | ﹤0.01% |
20,500
+15,227
| +289% | +$265K |
|
3924
Enanta Pharmaceuticals
ENTA
$400M
| $389K | ﹤0.01% |
41,300
+24,081
| +140% | +$224K |
|
3925
Maui Land & Pineapple Co
MLP
$344M
| $388K | ﹤0.01% |
24,388
+8,958
| +58% | +$132K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.